1. Home
  2. TRIB

as 07-12-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Nasdaq

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

Founded: 1992 Country:
Ireland
Ireland
Employees: N/A City: N/A
Market Cap: 19.3M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 59.4K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 4.25 EPS Growth: N/A
52 Week Low/High: $1.49 - $5.25 Next Earning Date: 05-23-2024
Revenue: $56,707,000 Revenue Growth: -8.06%
Revenue Growth (this year): 20.25% Revenue Growth (next year): 9.70%

TRIB Daily Stock ML Predictions

Share on Social Networks: